SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-083195
Filing Date
2024-07-12
Accepted
2024-07-12 16:04:05
Documents
8
Effectiveness Date
2024-07-12

Document Format Files

Seq Description Document Type Size
1 S-8 rare_2024_07_12_s-8.htm S-8 98347
2 EX-4.4 rare-ex4_4.htm EX-4.4 134050
3 EX-4.7 rare-ex4_7.htm EX-4.7 15619
4 EX-5.1 rare-ex5_1.htm EX-5.1 14054
5 EX-23.1 rare-ex23_1.htm EX-23.1 3945
6 EX-FILING FEES rare-exfiling_fees.htm EX-FILING FEES 24116
7 GRAPHIC img163890588_0.jpg GRAPHIC 35539
8 GRAPHIC img163890588_1.jpg GRAPHIC 35539
  Complete submission text file 0000950170-24-083195.txt   389332
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280776 | Film No.: 241114486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)